Cargando…
An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum
AIMS: Renin–angiotensin–aldosterone system inhibitors (RAASi) are guideline‐recommended therapy for individuals with cardiorenal disease. They are associated with increased risk of hyperkalaemia, a common and life‐threatening disorder for this population. RAASi‐induced hyperkalaemia often leads to d...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804940/ https://www.ncbi.nlm.nih.gov/pubmed/35791065 http://dx.doi.org/10.1002/ejhf.2612 |